ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

ClinicalTrials.gov ID: NCT01906866

Public ClinicalTrials.gov record NCT01906866. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 1:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of Circadin® to Alleviate Sleep Disturbances in Children With Neurodevelopmental Disabilities

Study identification

NCT ID
NCT01906866
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Neurim Pharmaceuticals Ltd.
Industry
Enrollment
125 participants

Conditions and interventions

Interventions

  • Circadin 2/5/10 mg Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
2 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2013
Primary completion
Mar 26, 2018
Completion
Mar 26, 2018
Last update posted
Apr 22, 2024

2013 – 2018

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
Southwest Autism Research and Resource Center (SARRC) Phoenix Arizona 85006
Crystal BioMedical Research, LLC Miami Lakes Florida 33014
Lake Mary Pediatrics Orange City Florida 32763
Mate Lazlo West Palm Beach Florida 33408
Attalla Consultants LLC, dba Institue for Behabiovral medicine Smyrna Georgia 30080-6315
AMR Baber research INC Naperville Illinois 60563
Kennedy Krieger Institute Baltimore Maryland 21205
Child Neurology Specialists/ CRCN Henderson Nevada 89052
Clinical research center of New Jersey, LLC Voorhees Township New Jersey 08043
Geinsinger Clinic Danville Pennsylvania 17822
The children's hospital of Philadelphia Philadelphia Pennsylvania 19104-4399
Vanderbilt University Nashville Tennessee 37240
INSITE Clinical Research DeSoto Texas 75115
Red Oak Psychiatry Associates Houston Texas 77090
Sleep Therapy & Research Center San Antonio Texas 78229
Road Runner Research, Ltd San Antonio Texas 78258
Ericksen Research & Development Clinton Utah 32763
Pacific institute of medical science Bothell Washington 98011

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01906866, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2024 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01906866 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →